UNITY BIOTECHNOLOGY INC (UBX) Earnings History & Surprises
NASDAQ:UBX • US91381U2006
0.2001 USD
-0.1 (-33.41%)
At close: Jul 8, 2025
0.1754 USD
-0.02 (-12.34%)
After Hours: 7/8/2025, 8:00:01 PM
Past quarterly earnings results for UNITY BIOTECHNOLOGY INC (UBX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateAug 12, 2025
PeriodQ2 / 2025
EPS Estimate-$0.30
Revenue Estimate
Last Reported
Release DateApr 22, 2025
PeriodQ1 / 2025
EPS Reported-$0.43
EPS Surprise -6.44%
Revenue Surprise %
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -0.43 | -0.40 | -6.44% | -26.47% | - | - | ||
| Q4 2024 | -0.50 | -0.41 | -22.33% | -78.57% | 6.733M | -100.00% | - | |
| Q3 2024 | -0.38 | -0.42 | 8.68% | 42.42% | - | - | ||
| Q2 2024 | -0.31 | -0.47 | 33.56% | 63.53% | - | - | ||
| Q1 2024 | -0.34 | -0.48 | 29.48% | 55.26% | - | - | ||
| Q4 2023 | -0.28 | -0.73 | 61.55% | 72.00% | - | - | ||
| Q3 2023 | -0.66 | -0.97 | 32.05% | 51.47% | - | - | ||
| Q2 2023 | -0.85 | -0.86 | 1.71% | 55.26% | - | -100.00% | ||
| Q1 2023 | -0.76 | -1.09 | 30.58% | 72.86% | - | - | ||
| Q4 2022 | -1.00 | -1.06 | 5.55% | 44.44% | - | -100.00% | ||
| Q3 2022 | -1.36 | -1.66 | 18.23% | 54.67% | - | - | ||
| Q2 2022 | -1.90 | -2.83 | 32.77% | 40.63% | 236K | - | - | |
| Q1 2022 | -2.80 | -2.60 | -7.77% | 3.45% | - | - | ||
| Q4 2021 | -1.80 | -3.89 | 53.71% | 51.35% | 4.784M | - | - | |
| Q3 2021 | -3.00 | -3.75 | 20.02% | 42.31% | - | - | ||
| Q2 2021 | -3.20 | -3.10 | -3.07% | 15.79% | - | - | ||
| Q1 2021 | -2.90 | -3.83 | 24.34% | 46.30% | - | - | ||
| Q4 2020 | -3.70 | -4.76 | 22.29% | - | - | - | ||
| Q3 2020 | -5.20 | -4.96 | -4.86% | - | - | - | ||
| Q2 2020 | -3.80 | -5.17 | 26.43% | - | - | - | ||
| Q1 2020 | -5.40 | -5.12 | -5.52% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
3.37%
Max EPS beat (4)
33.56%
Min EPS beat (4)
-22.33%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, UBX has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, UBX has beaten the EPS estimates by 3.4% on average.
UNITY BIOTECHNOLOGY INC / UBX Earnings FAQ
What is the most recent earnings date for UBX stock?
UNITY BIOTECHNOLOGY INC (UBX) last reported earnings on 4/22/2025.
Did UNITY BIOTECHNOLOGY INC (UBX) beat earnings estimates last quarter?
UNITY BIOTECHNOLOGY INC (UBX) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does UBX stock beat earnings estimates?
In the last 4 quarters, UNITY BIOTECHNOLOGY INC (UBX) has beaten EPS estimates in 2 out of 4 releases.